LIDOCAINE HYDROCHLORIDE

LIDOCAINE HYDROCHLORIDE was reported 61323 times

LIDOCAINE HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 LOCAL ANAESTHETIC SYSTEMIC TOXICITY 770 0.7250
1 INSPIRATORY CAPACITY DECREASED 103 0.3718
2 SLEEP DISORDER THERAPY 68 0.3434
3 DEVICE WIRELESS COMMUNICATION ISSUE 69 0.2664
4 APPENDICOLITH 101 0.2610
5 ANALGESIC THERAPY 70 0.2181
6 INFUSION SITE DISCHARGE 366 0.2085
7 DRUG THERAPY 68 0.2006
8 MATERNAL EXPOSURE DURING DELIVERY 195 0.1968
9 DEVICE MAINTENANCE ISSUE 110 0.1871
10 TOXIC ANTERIOR SEGMENT SYNDROME 199 0.1824
11 INFUSION SITE HAEMORRHAGE 472 0.1433
12 METHAEMOGLOBINAEMIA 301 0.1299
13 INFUSION SITE MASS 133 0.1224
14 INFUSION SITE IRRITATION 157 0.1222
15 INFUSION SITE NODULE 113 0.1176
16 INFUSION SITE WARMTH 144 0.1175
17 INFUSION SITE PRURITUS 360 0.1140
18 INFUSION SITE SWELLING 716 0.1137
19 BODY TINEA 60 0.1071
20 INFUSION SITE DISCOLOURATION 94 0.1068
21 INFUSION SITE BRUISING 228 0.1055
22 INFUSION SITE PAIN 1336 0.1036
23 INFUSION SITE INDURATION 152 0.1025
24 INFUSION SITE ERYTHEMA 855 0.1013
25 INFUSION SITE URTICARIA 67 0.1000
26 DEVICE INFUSION ISSUE 244 0.0983
27 INFUSION SITE DISCOMFORT 100 0.0964
28 INFUSION SITE INFLAMMATION 67 0.0949
29 CAUDA EQUINA SYNDROME 70 0.0911
30 INFUSION SITE RASH 123 0.0896
31 FOETAL EXPOSURE DURING DELIVERY 55 0.0811
32 INFUSION SITE INFECTION 186 0.0800
33 PROCEDURAL HYPOTENSION 67 0.0787
34 ANAESTHETIC COMPLICATION 208 0.0774
35 ANAESTHETIC COMPLICATION NEUROLOGICAL 65 0.0717
36 INFUSION SITE REACTION 203 0.0679
37 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 63 0.0593
38 KOUNIS SYNDROME 132 0.0581
39 DELAYED RECOVERY FROM ANAESTHESIA 51 0.0538
40 HYPERTHERMIA MALIGNANT 79 0.0531
41 MASTOIDITIS 52 0.0530
42 HYPERPHOSPHATAEMIA 112 0.0520
43 NEPHROGENIC ANAEMIA 224 0.0483
44 HYPERPARATHYROIDISM SECONDARY 121 0.0482
45 INCORRECT DRUG ADMINISTRATION RATE 196 0.0460
46 INFUSION SITE EXTRAVASATION 261 0.0419
47 BLOOD PHOSPHORUS INCREASED 109 0.0399
48 VASOPLEGIA SYNDROME 63 0.0384
49 MULTIPLE ALLERGIES 300 0.0382
50 OPHTHALMOPLEGIA 59 0.0374
51 INHIBITORY DRUG INTERACTION 54 0.0341
52 CORNEAL OEDEMA 76 0.0339
53 DERMATITIS CONTACT 386 0.0338
54 ANAPHYLACTIC SHOCK 869 0.0337
55 INSURANCE ISSUE 512 0.0334
56 SEASONAL ALLERGY 460 0.0325
57 DEVICE ALARM ISSUE 58 0.0319
58 PULSELESS ELECTRICAL ACTIVITY 129 0.0308
59 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 102 0.0308
60 VENTRICULAR FIBRILLATION 342 0.0308
61 STRESS CARDIOMYOPATHY 168 0.0289
62 DEVICE POWER SOURCE ISSUE 81 0.0277
63 INFECTION SUSCEPTIBILITY INCREASED 59 0.0269
64 REBOUND ACID HYPERSECRETION 79 0.0261
65 PARAPLEGIA 74 0.0256
66 PURULENT DISCHARGE 107 0.0250
67 PULSE ABSENT 119 0.0250
68 VENTRICULAR TACHYCARDIA 410 0.0248
69 RESPIRATORY TRACT INFECTION VIRAL 57 0.0245
70 LUNG OPACITY 64 0.0243
71 IRON DEFICIENCY 108 0.0240
72 OTITIS MEDIA 78 0.0236
73 OBSTRUCTION 91 0.0228
74 CANCER PAIN 58 0.0227
75 RETINAL ARTERY OCCLUSION 56 0.0221
76 GENERALISED TONIC-CLONIC SEIZURE 363 0.0219
77 END STAGE RENAL DISEASE 397 0.0217
78 CATHETER SITE PAIN 56 0.0216
79 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 56 0.0214
80 TYPE I HYPERSENSITIVITY 75 0.0213
81 STATUS EPILEPTICUS 239 0.0211
82 HYPOPHOSPHATAEMIA 155 0.0210
83 ARTHRITIS BACTERIAL 86 0.0209
84 APNOEA 163 0.0209
85 CHRONIC SINUSITIS 78 0.0208
86 CARDIOGENIC SHOCK 296 0.0206
87 EAR INFECTION 537 0.0202
88 RESPIRATORY TRACT INFECTION 522 0.0200
89 POOR VENOUS ACCESS 207 0.0200
90 ENDOPHTHALMITIS 120 0.0200
91 VENTRICULAR HYPOKINESIA 64 0.0199
92 SINUSITIS 2019 0.0197
93 VASCULAR DEVICE INFECTION 88 0.0194
94 AORTIC STENOSIS 67 0.0192
95 BLOOD URIC ACID INCREASED 109 0.0189
96 DEAFNESS NEUROSENSORY 62 0.0188
97 LUMBAR SPINAL STENOSIS 55 0.0188
98 SKIN ABRASION 88 0.0186
99 HYPERCAPNIA 56 0.0186
100 ANAPHYLACTIC REACTION 1009 0.0182
101 MYASTHENIA GRAVIS 147 0.0182
102 BUNDLE BRANCH BLOCK LEFT 77 0.0181
103 HAEMODYNAMIC INSTABILITY 137 0.0180
104 VENTRICULAR ARRHYTHMIA 65 0.0178
105 UPPER RESPIRATORY TRACT INFECTION 814 0.0176
106 PRODUCT DISTRIBUTION ISSUE 163 0.0176
107 SINUS TACHYCARDIA 249 0.0175
108 STRIDOR 51 0.0173
109 HYPERVOLAEMIA 85 0.0172
110 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 88 0.0172
111 RHINOVIRUS INFECTION 66 0.0169
112 PRODUCT ADMINISTRATION INTERRUPTED 132 0.0168
113 ATELECTASIS 158 0.0163
114 PROCTALGIA 105 0.0163
115 HYPERLIPIDAEMIA 195 0.0163
116 RESPIRATORY ACIDOSIS 64 0.0163
117 STREPTOCOCCAL INFECTION 90 0.0162
118 SPINAL OSTEOARTHRITIS 142 0.0161
119 PRODUCT ADHESION ISSUE 574 0.0160
120 GLUCOSE TOLERANCE IMPAIRED 94 0.0159
121 ANHEDONIA 417 0.0159
122 SKIN INFECTION 177 0.0158
123 ARTHRITIS INFECTIVE 73 0.0157
124 LIVE BIRTH 131 0.0156
125 NYSTAGMUS 83 0.0156
126 APPENDICITIS 146 0.0156
127 BRONCHOSPASM 220 0.0154
128 CARDIAC ARREST 1272 0.0154
129 MENINGITIS ASEPTIC 69 0.0154
130 HYPOXIA 533 0.0151
131 GASTROENTERITIS VIRAL 273 0.0151
132 RENAL INJURY 445 0.0150
133 VENTRICULAR EXTRASYSTOLES 155 0.0149
134 MYDRIASIS 190 0.0148
135 SPINAL CORD COMPRESSION 57 0.0146
136 TENDERNESS 152 0.0146
137 UNRESPONSIVE TO STIMULI 375 0.0145
138 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 249 0.0145
139 BRADYCARDIA 768 0.0145
140 MULTI-ORGAN FAILURE 248 0.0143
141 SKIN NECROSIS 74 0.0142
142 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 72 0.0142
143 RESPIRATORY DEPRESSION 174 0.0142
144 FEAR 377 0.0140
145 BRONCHIECTASIS 94 0.0139
146 SINUS BRADYCARDIA 134 0.0138
147 PARADOXICAL DRUG REACTION 51 0.0138
148 PHARYNGITIS STREPTOCOCCAL 150 0.0138
149 INTERVERTEBRAL DISC DEGENERATION 128 0.0138
150 SKIN LACERATION 149 0.0137
151 PROCEDURAL COMPLICATION 105 0.0137
152 POST PROCEDURAL COMPLICATION 261 0.0136
153 BACTERIAL INFECTION 253 0.0135
154 TOOTH INFECTION 176 0.0133
155 TORSADE DE POINTES 103 0.0131
156 NEURALGIA 317 0.0130
157 CIRCULATORY COLLAPSE 221 0.0130
158 HAEMOGLOBIN INCREASED 59 0.0129
159 NEUROTOXICITY 226 0.0129
160 GASTROINTESTINAL INFECTION 115 0.0128
161 HYPOAESTHESIA ORAL 193 0.0128
162 DECUBITUS ULCER 104 0.0127
163 SENSORY LOSS 102 0.0127
164 HYPERURICAEMIA 52 0.0126
165 TROPONIN INCREASED 95 0.0125
166 ANAPHYLACTOID REACTION 51 0.0124
167 DEVICE OCCLUSION 173 0.0123
168 BRONCHITIS 908 0.0123
169 MENTAL STATUS CHANGES 339 0.0122
170 SINUS DISORDER 241 0.0122
171 STAPHYLOCOCCAL INFECTION 401 0.0121
172 RHINITIS ALLERGIC 54 0.0121
173 DIVERTICULUM INTESTINAL 53 0.0121
174 THERAPY PARTIAL RESPONDER 189 0.0121
175 RALES 70 0.0120
176 HYPERAESTHESIA 99 0.0120
177 PERIPHERAL VASCULAR DISORDER 62 0.0120
178 BRAIN OEDEMA 152 0.0120
179 HORDEOLUM 52 0.0120
180 BENIGN PROSTATIC HYPERPLASIA 62 0.0120
181 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 106 0.0120
182 BREATH SOUNDS ABNORMAL 59 0.0120
183 CHRONIC KIDNEY DISEASE 897 0.0118
184 SUPRAVENTRICULAR TACHYCARDIA 113 0.0118
185 NORMAL NEWBORN 64 0.0118
186 STAPHYLOCOCCAL SEPSIS 58 0.0117
187 RESPIRATORY SYNCYTIAL VIRUS INFECTION 102 0.0117
188 MIOSIS 94 0.0117
189 PSEUDOMONAS INFECTION 100 0.0116
190 PHARYNGITIS 143 0.0115
191 EYE INFECTION 130 0.0115
192 MONOPLEGIA 50 0.0115
193 LEFT VENTRICULAR DYSFUNCTION 77 0.0115
194 MYOCLONUS 137 0.0115
195 KIDNEY INFECTION 225 0.0115
196 VIRAL INFECTION 380 0.0114
197 ACUTE RESPIRATORY FAILURE 219 0.0114
198 SHOCK 261 0.0113
199 CANDIDA INFECTION 191 0.0113
200 WEIGHT FLUCTUATION 118 0.0113
201 SPINAL COLUMN STENOSIS 53 0.0112
202 LARYNGEAL OEDEMA 69 0.0112
203 POST PROCEDURAL INFECTION 90 0.0111
204 HYPOALBUMINAEMIA 86 0.0110
205 VARICOSE VEIN 57 0.0110
206 CELLULITIS 545 0.0108
207 PRE-EXISTING CONDITION IMPROVED 67 0.0107
208 JOINT EFFUSION 74 0.0107
209 CYSTITIS 341 0.0107
210 TOOTH ABSCESS 109 0.0107
211 HAEMORRHOIDS 207 0.0106
212 RENAL TUBULAR NECROSIS 104 0.0106
213 PRODUCT LEAKAGE 59 0.0105
214 MENINGITIS 70 0.0105
215 ATRIOVENTRICULAR BLOCK COMPLETE 70 0.0104
216 TRISMUS 54 0.0104
217 IMPAIRED QUALITY OF LIFE 149 0.0104
218 NERVE INJURY 115 0.0103
219 FEBRILE NEUTROPENIA 686 0.0103
220 FOOD POISONING 55 0.0103
221 BLOOD LACTIC ACID INCREASED 54 0.0102
222 INFUSION RELATED REACTION 677 0.0102
223 ESCHERICHIA INFECTION 84 0.0102
224 FACIAL PARALYSIS 87 0.0102
225 HYPOTENSION 2045 0.0102
226 ACUTE PULMONARY OEDEMA 57 0.0101
227 HEPARIN-INDUCED THROMBOCYTOPENIA 50 0.0101
228 GRAND MAL CONVULSION 93 0.0101
229 OXYGEN SATURATION DECREASED 565 0.0100
230 CYANOSIS 158 0.0100
231 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 78 0.0100
232 HIATUS HERNIA 130 0.0100
233 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 549 0.0100
234 TACHYPNOEA 136 0.0100
235 CARDIOTOXICITY 89 0.0100
236 LOCALISED INFECTION 241 0.0100
237 THERAPY NON-RESPONDER 447 0.0099
238 ECCHYMOSIS 68 0.0099
239 CONCUSSION 76 0.0098
240 ORAL CANDIDIASIS 129 0.0098
241 RIB FRACTURE 201 0.0098
242 MUSCULOSKELETAL CHEST PAIN 151 0.0097
243 IRON DEFICIENCY ANAEMIA 90 0.0097
244 RENAL FAILURE 1293 0.0097
245 SCIATICA 155 0.0097
246 PURPURA 86 0.0097
247 INJURY 678 0.0096
248 GINGIVITIS 52 0.0096
249 TACHYCARDIA 856 0.0096
250 FAILURE TO THRIVE 50 0.0096
251 SKIN WARM 56 0.0096
252 IMPAIRED GASTRIC EMPTYING 131 0.0096
253 HYPERKERATOSIS 53 0.0096
254 FOOD ALLERGY 74 0.0096
255 ARTHROPOD BITE 71 0.0096
256 POOR QUALITY SLEEP 206 0.0096
257 TRICUSPID VALVE INCOMPETENCE 76 0.0096
258 LYMPHOCYTE COUNT DECREASED 169 0.0096
259 URINARY TRACT INFECTION 1627 0.0095
260 ECONOMIC PROBLEM 144 0.0095
261 ROTATOR CUFF SYNDROME 122 0.0095
262 PAIN IN JAW 269 0.0095
263 WRONG PRODUCT ADMINISTERED 64 0.0095
264 ANAL ABSCESS 51 0.0095
265 RESPIRATORY TRACT CONGESTION 150 0.0094
266 MULTIPLE ORGAN DYSFUNCTION SYNDROME 267 0.0094
267 PRODUCTIVE COUGH 449 0.0094
268 SENSITIVE SKIN 69 0.0093
269 RENAL CYST 74 0.0093
270 COVID-19 PNEUMONIA 110 0.0093
271 SPINAL PAIN 109 0.0093
272 RETINAL HAEMORRHAGE 66 0.0093
273 OBSTRUCTIVE AIRWAYS DISORDER 103 0.0093
274 FACIAL PAIN 82 0.0092
275 PARAESTHESIA ORAL 132 0.0091
276 MALNUTRITION 102 0.0091
277 OSTEOMYELITIS 165 0.0091
278 LIGAMENT SPRAIN 90 0.0091
279 PNEUMOTHORAX 144 0.0091
280 DEVICE PHYSICAL PROPERTY ISSUE 69 0.0090
281 EXOSTOSIS 82 0.0090
282 ILLNESS 924 0.0090
283 CARDIO-RESPIRATORY ARREST 375 0.0090
284 LYMPHOEDEMA 62 0.0090
285 DRUG LEVEL INCREASED 148 0.0089
286 MUSCLE STRAIN 77 0.0089
287 HAND FRACTURE 63 0.0089
288 LIMB INJURY 241 0.0089
289 DEVICE FAILURE 135 0.0089
290 CARDIOMEGALY 109 0.0089
291 EYELID PTOSIS 90 0.0088
292 FLANK PAIN 83 0.0088
293 PULMONARY HYPERTENSION 184 0.0088
294 RESPIRATORY DISTRESS 243 0.0088
295 FIBROMYALGIA 214 0.0088
296 TOXICITY TO VARIOUS AGENTS 1484 0.0088
297 INCONTINENCE 93 0.0088
298 DIPLOPIA 228 0.0088
299 SCAR 150 0.0088
300 SLEEP APNOEA SYNDROME 167 0.0087
301 SPINAL COMPRESSION FRACTURE 72 0.0087
302 RESPIRATORY ARREST 240 0.0087
303 BLOOD ALBUMIN DECREASED 69 0.0087
304 NERVE COMPRESSION 80 0.0087
305 SINUS CONGESTION 117 0.0087
306 VITREOUS FLOATERS 85 0.0086
307 ORAL DISORDER 63 0.0086
308 POSTOPERATIVE WOUND INFECTION 58 0.0086
309 ASPIRATION 94 0.0086
310 DIZZINESS POSTURAL 83 0.0086
311 COVID-19 1497 0.0085
312 OSTEOPENIA 129 0.0085
313 LUNG INFILTRATION 75 0.0085
314 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 443 0.0085
315 DYSARTHRIA 319 0.0085
316 HYPOKALAEMIA 390 0.0084
317 FOOT FRACTURE 160 0.0084
318 MOTOR DYSFUNCTION 86 0.0084
319 VITAMIN D DEFICIENCY 82 0.0084
320 BLOOD PRESSURE DECREASED 557 0.0084
321 UPPER-AIRWAY COUGH SYNDROME 69 0.0084
322 DRUG TOXICITY 114 0.0084
323 ULCER 133 0.0084
324 ANAL INCONTINENCE 75 0.0083
325 EYE MOVEMENT DISORDER 57 0.0083
326 AUTOIMMUNE DISORDER 81 0.0083
327 BODY TEMPERATURE INCREASED 169 0.0083
328 BACTERAEMIA 98 0.0082
329 BURSITIS 100 0.0082
330 OEDEMA 444 0.0082
331 PNEUMONIA BACTERIAL 75 0.0082
332 ARTERIOSCLEROSIS CORONARY ARTERY 54 0.0081
333 INTERVERTEBRAL DISC PROTRUSION 178 0.0081
334 CLOSTRIDIUM DIFFICILE COLITIS 86 0.0081
335 PARALYSIS 116 0.0081
336 ENCEPHALOPATHY 199 0.0081
337 DYSPNOEA EXERTIONAL 304 0.0081
338 DIVERTICULUM 57 0.0080
339 CARPAL TUNNEL SYNDROME 112 0.0080
340 RESPIRATION ABNORMAL 55 0.0080
341 PALLOR 217 0.0080
342 TOXIC EPIDERMAL NECROLYSIS 121 0.0080
343 SMALL INTESTINAL OBSTRUCTION 98 0.0080
344 MUSCULOSKELETAL DISCOMFORT 137 0.0080
345 SEROTONIN SYNDROME 152 0.0079
346 NECK PAIN 442 0.0079
347 CONJUNCTIVITIS 146 0.0079
348 BLOOD CALCIUM INCREASED 69 0.0079
349 WOUND INFECTION 86 0.0078
350 GOUT 140 0.0078
351 DELIRIUM 270 0.0078
352 PULMONARY OEDEMA 348 0.0078
353 INADEQUATE ANALGESIA 66 0.0078
354 PHARYNGEAL SWELLING 76 0.0078
355 SEPSIS 866 0.0078
356 RIGHT VENTRICULAR FAILURE 54 0.0077
357 MITRAL VALVE INCOMPETENCE 87 0.0077
358 DEPRESSED LEVEL OF CONSCIOUSNESS 304 0.0077
359 JOINT INJURY 164 0.0077
360 HERPES ZOSTER 440 0.0077
361 BRAIN FOG 120 0.0076
362 MASS 107 0.0076
363 ASCITES 225 0.0076
364 ORAL PAIN 171 0.0076
365 PLEURAL EFFUSION 464 0.0076
366 NEUTROPHIL COUNT INCREASED 78 0.0076
367 POST-TRAUMATIC STRESS DISORDER 51 0.0076
368 UNEVALUABLE EVENT 573 0.0076
369 HAEMATOCRIT DECREASED 150 0.0076
370 PREMATURE DELIVERY 120 0.0075
371 PNEUMONIA ASPIRATION 188 0.0075
372 PULMONARY MASS 112 0.0075
373 RESPIRATORY FAILURE 548 0.0075
374 ORAL HERPES 146 0.0075
375 OSTEOARTHRITIS 317 0.0075
376 JOINT DISLOCATION 79 0.0075
377 HYPERCHOLESTEROLAEMIA 72 0.0074
378 BLOOD UREA INCREASED 124 0.0074
379 LEUKOCYTOSIS 134 0.0074
380 FUNGAL INFECTION 245 0.0073
381 METABOLIC ACIDOSIS 235 0.0073
382 MIGRAINE 700 0.0073
383 PNEUMONIA 2372 0.0073
384 DISSEMINATED INTRAVASCULAR COAGULATION 103 0.0073
385 ACCIDENT 87 0.0073
386 INFLUENZA 808 0.0072
387 ILEUS 90 0.0072
388 DENTAL CARIES 80 0.0072
389 MOUTH HAEMORRHAGE 53 0.0072
390 CYTOKINE RELEASE SYNDROME 145 0.0072
391 APHTHOUS ULCER 56 0.0072
392 CONTUSION 695 0.0072
393 PULMONARY CONGESTION 95 0.0072
394 RHINITIS 58 0.0072
395 BLINDNESS TRANSIENT 53 0.0072
396 RENAL FAILURE CHRONIC 55 0.0071
397 HEREDITARY ANGIOEDEMA 76 0.0071
398 EAR PAIN 137 0.0070
399 APHONIA 98 0.0070
400 CLOSTRIDIUM DIFFICILE INFECTION 153 0.0070
401 ELECTROCARDIOGRAM QT PROLONGED 252 0.0070
402 NEPHROPATHY 65 0.0070
403 GROIN PAIN 61 0.0069
404 HYDRONEPHROSIS 52 0.0069
405 PREMATURE BABY 209 0.0069
406 BLOOD PRESSURE ABNORMAL 138 0.0069
407 EMPHYSEMA 70 0.0069
408 BODY HEIGHT DECREASED 74 0.0069
409 SEIZURE 798 0.0069
410 SPINAL DISORDER 65 0.0069
411 JOINT RANGE OF MOTION DECREASED 92 0.0069
412 ATRIOVENTRICULAR BLOCK 53 0.0068
413 SPUTUM DISCOLOURED 65 0.0068
414 HEMIPARESIS 116 0.0068
415 MOUTH ULCERATION 144 0.0068
416 STOMATITIS 414 0.0068
417 DEVICE RELATED INFECTION 105 0.0068
418 PYELONEPHRITIS 59 0.0068
419 OSTEOPOROSIS 280 0.0068
420 BONE DISORDER 124 0.0068
421 GINGIVAL PAIN 54 0.0068
422 BRAIN INJURY 68 0.0068
423 BACK PAIN 1575 0.0068
424 BLOOD PRESSURE DIASTOLIC DECREASED 50 0.0068
425 ACUTE KIDNEY INJURY 1035 0.0068
426 PULMONARY ARTERIAL HYPERTENSION 98 0.0068
427 HYPOMAGNESAEMIA 94 0.0067
428 BLADDER DISORDER 67 0.0067
429 RETINAL DETACHMENT 62 0.0067
430 PROCEDURAL PAIN 187 0.0067
431 ATAXIA 80 0.0067
432 TOOTHACHE 122 0.0067
433 BLOOD MAGNESIUM DECREASED 58 0.0067
434 LOSS OF CONSCIOUSNESS 860 0.0067
435 SKIN ULCER 173 0.0067
436 DIVERTICULITIS 184 0.0066
437 SUBSTANCE ABUSE 54 0.0066
438 HYPONATRAEMIA 373 0.0066
439 POST PROCEDURAL HAEMORRHAGE 77 0.0066
440 UROSEPSIS 61 0.0066
441 SWELLING 618 0.0066
442 BLOOD CALCIUM DECREASED 74 0.0066
443 HEART RATE DECREASED 231 0.0066
444 MICTURITION URGENCY 75 0.0066
445 BACK INJURY 71 0.0065
446 ATRIAL FLUTTER 52 0.0065
447 ELECTROCARDIOGRAM ABNORMAL 51 0.0065
448 OESOPHAGITIS 71 0.0065
449 GENERALISED OEDEMA 80 0.0065
450 ABSCESS 103 0.0064
451 ATRIAL FIBRILLATION 628 0.0064
452 NASOPHARYNGITIS 1187 0.0064
453 ACCIDENTAL OVERDOSE 235 0.0064
454 MUCOSAL INFLAMMATION 168 0.0064
455 ALTERED STATE OF CONSCIOUSNESS 139 0.0064
456 ANKLE FRACTURE 99 0.0064
457 ARTERIOSCLEROSIS 60 0.0064
458 INFECTION 922 0.0064
459 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1148 0.0064
460 CHILLS 744 0.0063
461 CATARACT 377 0.0063
462 NEPHROLITHIASIS 290 0.0063
463 BLOOD POTASSIUM DECREASED 190 0.0063
464 HEPATOMEGALY 62 0.0063
465 LOW BIRTH WEIGHT BABY 50 0.0063
466 RESPIRATORY DISORDER 188 0.0063
467 NODULE 82 0.0063
468 HAEMOPTYSIS 175 0.0063
469 PRODUCT DOSE OMISSION ISSUE 1839 0.0062
470 SPINAL OPERATION 77 0.0062
471 GASTROOESOPHAGEAL REFLUX DISEASE 501 0.0062
472 HICCUPS 51 0.0062
473 BACK DISORDER 101 0.0062
474 TOOTH DISORDER 138 0.0062
475 HYPERTENSIVE CRISIS 69 0.0062
476 ELECTROLYTE IMBALANCE 72 0.0062
477 TUBULOINTERSTITIAL NEPHRITIS 116 0.0062
478 SPINAL FRACTURE 124 0.0062
479 INTRAOCULAR PRESSURE INCREASED 79 0.0062
480 HOSPICE CARE 61 0.0062
481 APHASIA 186 0.0062
482 PAIN 3749 0.0061
483 COMA 290 0.0061
484 MUSCLE TWITCHING 140 0.0061
485 HEAD INJURY 192 0.0061
486 MYOCARDIAL ISCHAEMIA 69 0.0061
487 RENAL FAILURE ACUTE 257 0.0061
488 URINARY INCONTINENCE 179 0.0060
489 INABILITY TO AFFORD MEDICATION 60 0.0060
490 DRUG INTERACTION 958 0.0060
491 ACUTE CORONARY SYNDROME 50 0.0060
492 HYPOCALCAEMIA 114 0.0060
493 MUSCLE RIGIDITY 72 0.0060
494 COLD SWEAT 106 0.0060
495 MUSCLE TIGHTNESS 97 0.0060
496 RESPIRATORY RATE INCREASED 53 0.0060
497 QUALITY OF LIFE DECREASED 80 0.0060
498 URINARY RETENTION 198 0.0059
499 ANXIETY 1687 0.0059
500 IRRITABLE BOWEL SYNDROME 127 0.0059
501 OROPHARYNGEAL PAIN 548 0.0059
502 HYPOTONIA 59 0.0059
503 BLOOD IRON DECREASED 70 0.0059
504 SUBARACHNOID HAEMORRHAGE 60 0.0059
505 CARDIOMYOPATHY 87 0.0059
506 DISCOMFORT 358 0.0059
507 PRESYNCOPE 142 0.0058
508 HYPERTENSION 1237 0.0058
509 BLOOD SODIUM DECREASED 110 0.0058
510 RESTLESS LEGS SYNDROME 106 0.0058
511 HAEMATOMA 151 0.0058
512 ACUTE RESPIRATORY DISTRESS SYNDROME 103 0.0058
513 APPLICATION SITE PAIN 128 0.0058
514 ANGIOEDEMA 257 0.0058
515 TOOTH FRACTURE 64 0.0058
516 FALL 1929 0.0058
517 HYPERKALAEMIA 203 0.0058
518 PULMONARY THROMBOSIS 63 0.0058
519 FOOT DEFORMITY 64 0.0058
520 PYREXIA 1998 0.0058
521 FULL BLOOD COUNT ABNORMAL 61 0.0058
522 NEUTROPHIL COUNT DECREASED 235 0.0058
523 EYE INFLAMMATION 55 0.0058
524 OROPHARYNGEAL DISCOMFORT 52 0.0058
525 LACERATION 54 0.0057
526 LYMPHADENOPATHY 203 0.0057
527 EJECTION FRACTION DECREASED 89 0.0057
528 TINNITUS 263 0.0057
529 BLOOD PRESSURE INCREASED 875 0.0057
530 DISABILITY 113 0.0057
531 FLUID RETENTION 290 0.0057
532 LIMB DISCOMFORT 176 0.0057
533 LETHARGY 325 0.0056
534 CYST 70 0.0056
535 SKIN DISORDER 188 0.0056
536 COUGH 1578 0.0056
537 TENDONITIS 87 0.0056
538 NEUROPATHY PERIPHERAL 534 0.0056
539 SEPTIC SHOCK 244 0.0056
540 WRIST FRACTURE 67 0.0056
541 PERICARDIAL EFFUSION 129 0.0056
542 EXPOSURE DURING PREGNANCY 346 0.0056
543 DERMATITIS ALLERGIC 70 0.0056
544 BLOOD TEST ABNORMAL 78 0.0055
545 RESTLESSNESS 203 0.0055
546 LOWER RESPIRATORY TRACT INFECTION 252 0.0055
547 ABDOMINAL DISTENSION 577 0.0055
548 WHITE BLOOD CELL COUNT INCREASED 212 0.0055
549 ASPARTATE AMINOTRANSFERASE INCREASED 293 0.0055
550 WHEEZING 326 0.0055
551 NASAL CONGESTION 323 0.0055
552 ANAEMIA 1048 0.0055
553 TASTE DISORDER 111 0.0055
554 ERYTHEMA MULTIFORME 51 0.0055
555 HEADACHE 3425 0.0055
556 COMPLICATION ASSOCIATED WITH DEVICE 79 0.0054
557 EMOTIONAL DISTRESS 658 0.0054
558 INTENTIONAL PRODUCT USE ISSUE 476 0.0054
559 DEHYDRATION 724 0.0054
560 EPISTAXIS 406 0.0054
561 RED BLOOD CELL COUNT DECREASED 155 0.0054
562 UPPER LIMB FRACTURE 108 0.0054
563 C-REACTIVE PROTEIN INCREASED 197 0.0054
564 DEVICE DISLOCATION 235 0.0054
565 CONSTIPATION 1175 0.0054
566 HEART RATE INCREASED 533 0.0054
567 RENAL PAIN 57 0.0054
568 SYNCOPE 538 0.0054
569 BURNING SENSATION 376 0.0054
570 HYPOAESTHESIA 801 0.0053
571 OEDEMA PERIPHERAL 652 0.0053
572 ARRHYTHMIA 253 0.0053
573 CHEST PAIN 984 0.0053
574 LIVER FUNCTION TEST INCREASED 114 0.0053
575 RASH MACULO-PAPULAR 118 0.0053
576 PRODUCT USE IN UNAPPROVED INDICATION 1313 0.0053
577 BLISTER 297 0.0053
578 FACE OEDEMA 89 0.0053
579 UNINTENTIONAL MEDICAL DEVICE REMOVAL 61 0.0053
580 PERIPHERAL SWELLING 812 0.0053
581 PHOTOPHOBIA 99 0.0053
582 RENAL IMPAIRMENT 440 0.0052
583 HYPOTHYROIDISM 167 0.0052
584 CONFUSIONAL STATE 845 0.0052
585 DYSURIA 192 0.0052
586 OBESITY 83 0.0052
587 CHEST DISCOMFORT 533 0.0052
588 DYSPHAGIA 493 0.0052
589 WOUND 145 0.0052
590 ROAD TRAFFIC ACCIDENT 217 0.0052
591 EYE PAIN 292 0.0052
592 EATING DISORDER 110 0.0052
593 TOXIC SKIN ERUPTION 52 0.0052
594 BLOOD URINE PRESENT 98 0.0052
595 GASTROINTESTINAL DISORDER 460 0.0051
596 SPEECH DISORDER 269 0.0051
597 NERVOUS SYSTEM DISORDER 160 0.0051
598 VISUAL ACUITY REDUCED 170 0.0051
599 MUSCULOSKELETAL PAIN 268 0.0051
600 THROMBOSIS 411 0.0051
601 MATERNAL EXPOSURE DURING PREGNANCY 452 0.0051
602 BASAL CELL CARCINOMA 79 0.0051
603 LUNG DISORDER 248 0.0051
604 MUSCULAR WEAKNESS 575 0.0051
605 DYSPNOEA 2863 0.0051
606 COAGULOPATHY 84 0.0050
607 FEELING COLD 140 0.0050
608 POISONING 63 0.0050
609 CHROMATURIA 113 0.0050
610 VERTIGO 305 0.0050
611 OCULAR DISCOMFORT 56 0.0050
612 SKIN DISCOLOURATION 229 0.0050
613 WEIGHT DECREASED 1390 0.0050
614 HALLUCINATION, VISUAL 105 0.0050
615 ASTHMA 562 0.0050
616 EAR DISCOMFORT 51 0.0050
617 IMPAIRED WORK ABILITY 106 0.0050
618 HEART RATE IRREGULAR 112 0.0050
619 ARTHRITIS 389 0.0049
620 SOMNOLENCE 994 0.0049
621 VOMITING 2320 0.0049
622 SWOLLEN TONGUE 154 0.0049
623 DRY MOUTH 400 0.0049
624 SCRATCH 52 0.0049
625 BLOOD CHOLESTEROL INCREASED 229 0.0049
626 PAIN IN EXTREMITY 1445 0.0049
627 PULMONARY EMBOLISM 465 0.0049
628 DYSPHONIA 286 0.0049
629 BLOOD ALKALINE PHOSPHATASE INCREASED 121 0.0049
630 AGITATION 357 0.0049
631 ACUTE MYOCARDIAL INFARCTION 143 0.0048
632 NAUSEA 3838 0.0048
633 LOWER LIMB FRACTURE 93 0.0048
634 GASTRITIS 127 0.0048
635 DYSKINESIA 196 0.0048
636 MUSCLE ATROPHY 61 0.0048
637 DRUG INTOLERANCE 465 0.0048
638 RHINORRHOEA 310 0.0048
639 NEOPLASM 55 0.0048
640 CHOLECYSTITIS 57 0.0048
641 HEPATIC STEATOSIS 89 0.0048
642 LIP SWELLING 159 0.0048
643 MEDICATION ERROR 265 0.0048
644 GINGIVAL BLEEDING 65 0.0048
645 TREMOR 790 0.0048
646 BONE DENSITY DECREASED 149 0.0048
647 IMPAIRED HEALING 156 0.0047
648 PRODUCT ADMINISTRATION ERROR 96 0.0047
649 DYSTONIA 92 0.0047
650 ERYTHEMA 972 0.0047
651 MUSCLE SPASTICITY 58 0.0047
652 HERNIA 91 0.0047
653 INFLUENZA LIKE ILLNESS 387 0.0047
654 BLOOD BILIRUBIN INCREASED 127 0.0047
655 TENDON RUPTURE 58 0.0047
656 ADRENAL INSUFFICIENCY 57 0.0047
657 CHOLELITHIASIS 154 0.0047
658 FATIGUE 3654 0.0047
659 NIGHT SWEATS 151 0.0047
660 SNEEZING 105 0.0047
661 DECREASED APPETITE 1086 0.0047
662 SLEEP DISORDER 330 0.0047
663 PLATELET COUNT DECREASED 498 0.0047
664 NEEDLE ISSUE 136 0.0047
665 BLOOD PRESSURE SYSTOLIC INCREASED 91 0.0047
666 TOOTH EXTRACTION 58 0.0047
667 GALLBLADDER DISORDER 83 0.0046
668 RETCHING 99 0.0046
669 CAESAREAN SECTION 54 0.0046
670 FEEDING DISORDER 94 0.0046
671 EOSINOPHILIA 81 0.0046
672 BLOOD POTASSIUM INCREASED 75 0.0046
673 SARS-COV-2 TEST POSITIVE 61 0.0046
674 COLITIS 174 0.0046
675 PERIPHERAL COLDNESS 63 0.0046
676 HAIR COLOUR CHANGES 57 0.0046
677 URTICARIA 767 0.0046
678 ALANINE AMINOTRANSFERASE INCREASED 281 0.0046
679 HYPOPHAGIA 117 0.0046
680 GLAUCOMA 88 0.0046
681 SECRETION DISCHARGE 57 0.0045
682 CONVULSION 260 0.0045
683 SKIN LESION 124 0.0045
684 PNEUMONITIS 123 0.0045
685 DISORIENTATION 179 0.0045
686 METASTASES TO BONE 74 0.0045
687 ABDOMINAL PAIN 1047 0.0045
688 CORONARY ARTERY DISEASE 136 0.0045
689 PALPITATIONS 523 0.0045
690 PERICARDITIS 75 0.0045
691 LUNG INFECTION 69 0.0044
692 HAEMATURIA 152 0.0044
693 MACULAR DEGENERATION 53 0.0044
694 PARAESTHESIA 698 0.0044
695 DIZZINESS 2212 0.0044
696 PRODUCT USE ISSUE 832 0.0044
697 METASTASES TO LUNG 51 0.0044
698 THYROID DISORDER 68 0.0044
699 HYPOKINESIA 64 0.0044
700 HEAD DISCOMFORT 78 0.0044
701 OSTEONECROSIS OF JAW 109 0.0044
702 BLINDNESS 179 0.0044
703 BLOOD PRESSURE FLUCTUATION 105 0.0044
704 MUSCULOSKELETAL STIFFNESS 381 0.0043
705 DRUG ERUPTION 77 0.0043
706 BEDRIDDEN 57 0.0043
707 MUSCLE SPASMS 795 0.0043
708 SKIN REACTION 61 0.0043
709 MENTAL DISORDER 188 0.0043
710 HYPERSOMNIA 123 0.0043
711 FULL BLOOD COUNT DECREASED 86 0.0043
712 GASTRIC ULCER 81 0.0043
713 THROAT TIGHTNESS 115 0.0042
714 BONE PAIN 249 0.0042
715 DEEP VEIN THROMBOSIS 276 0.0042
716 HYPERSENSITIVITY 788 0.0042
717 INTESTINAL OBSTRUCTION 160 0.0042
718 INFLAMMATION 219 0.0042
719 PHOTOSENSITIVITY REACTION 70 0.0042
720 STEVENS-JOHNSON SYNDROME 94 0.0042
721 HAEMOGLOBIN DECREASED 432 0.0042
722 ARTHROPATHY 233 0.0042
723 PANCYTOPENIA 234 0.0042
724 SWELLING FACE 272 0.0042
725 BALANCE DISORDER 361 0.0042
726 TRANSIENT ISCHAEMIC ATTACK 140 0.0041
727 APPLICATION SITE RASH 57 0.0041
728 HYPERHIDROSIS 533 0.0041
729 SEDATION 108 0.0041
730 DRUG EFFECT LESS THAN EXPECTED 61 0.0041
731 DERMATITIS 86 0.0041
732 GAIT INABILITY 137 0.0041
733 APPLICATION SITE ERYTHEMA 107 0.0041
734 BLOOD CREATININE INCREASED 266 0.0041
735 RECTAL HAEMORRHAGE 175 0.0041
736 PULMONARY FIBROSIS 78 0.0041
737 DIABETES MELLITUS 309 0.0040
738 COGNITIVE DISORDER 189 0.0040
739 ASTHENIA 1521 0.0040
740 PRODUCT AVAILABILITY ISSUE 92 0.0040
741 GAIT DISTURBANCE 770 0.0040
742 DIARRHOEA 2594 0.0040
743 PRODUCT QUALITY ISSUE 545 0.0040
744 CENTRAL NERVOUS SYSTEM LESION 55 0.0040
745 WHITE BLOOD CELL COUNT DECREASED 433 0.0040
746 ARTHRALGIA 1659 0.0040
747 SUBDURAL HAEMATOMA 57 0.0040
748 DEPRESSION 905 0.0040
749 DYSSTASIA 116 0.0040
750 THROAT IRRITATION 178 0.0040
751 RASH PRURITIC 215 0.0040
752 FLUSHING 402 0.0040
753 METASTASES TO CENTRAL NERVOUS SYSTEM 51 0.0040
754 IMMUNE SYSTEM DISORDER 52 0.0039
755 SENSORY DISTURBANCE 63 0.0039
756 HIP FRACTURE 126 0.0039
757 DRUG ABUSE 326 0.0039
758 BLOOD TRIGLYCERIDES INCREASED 69 0.0039
759 PRODUCT PRESCRIBING ISSUE 85 0.0039
760 HAIR TEXTURE ABNORMAL 52 0.0039
761 CARDIAC FAILURE 312 0.0039
762 PRODUCT DOSE OMISSION IN ERROR 110 0.0039
763 RASH 1691 0.0039
764 DEAFNESS 101 0.0039
765 DISTURBANCE IN ATTENTION 208 0.0039
766 PELVIC PAIN 70 0.0038
767 PRODUCT PREPARATION ERROR 79 0.0038
768 HYPERGLYCAEMIA 140 0.0038
769 SURGERY 225 0.0038
770 MALAISE 1679 0.0038
771 AMNESIA 248 0.0038
772 ANGINA PECTORIS 109 0.0038
773 COORDINATION ABNORMAL 53 0.0038
774 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 270 0.0038
775 INTENTIONAL PRODUCT MISUSE 332 0.0038
776 DYSPEPSIA 373 0.0038
777 LACRIMATION INCREASED 114 0.0038
778 OFF LABEL USE 3295 0.0038
779 VISION BLURRED 516 0.0038
780 HALLUCINATION 283 0.0038
781 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 180 0.0037
782 POLLAKIURIA 156 0.0037
783 PSYCHOMOTOR HYPERACTIVITY 62 0.0037
784 HYPERTHYROIDISM 54 0.0037
785 BLOOD LACTATE DEHYDROGENASE INCREASED 59 0.0037
786 FEELING HOT 228 0.0037
787 RENAL DISORDER 173 0.0037
788 ACTIVITIES OF DAILY LIVING IMPAIRED 73 0.0037
789 PRODUCT USE COMPLAINT 58 0.0037
790 ORAL DISCOMFORT 51 0.0037
791 JOINT STIFFNESS 96 0.0037
792 THROMBOCYTOPENIA 409 0.0037
793 MYALGIA 620 0.0036
794 INCORRECT PRODUCT ADMINISTRATION DURATION 79 0.0036
795 FLUID OVERLOAD 53 0.0036
796 CARDIAC FAILURE CONGESTIVE 292 0.0036
797 OVERDOSE 783 0.0036
798 CONDITION AGGRAVATED 1103 0.0036
799 OSTEONECROSIS 119 0.0036
800 HEPATIC CIRRHOSIS 68 0.0036
801 HEPATIC FUNCTION ABNORMAL 135 0.0036
802 INTENTIONAL DOSE OMISSION 103 0.0036
803 INSOMNIA 958 0.0036
804 WEIGHT INCREASED 805 0.0036
805 MOBILITY DECREASED 258 0.0036
806 MENTAL IMPAIRMENT 87 0.0036
807 GENERAL PHYSICAL HEALTH DETERIORATION 415 0.0036
808 SKIN CANCER 77 0.0036
809 TOOTH LOSS 74 0.0036
810 ORTHOSTATIC HYPOTENSION 62 0.0036
811 EYE DISORDER 117 0.0036
812 DEVICE LEAKAGE 154 0.0035
813 SYNOVITIS 64 0.0035
814 DRY EYE 177 0.0035
815 PREGNANCY 71 0.0035
816 PARANOIA 61 0.0035
817 CARDIAC DISORDER 330 0.0035
818 PHARYNGEAL OEDEMA 54 0.0035
819 HAEMORRHAGE 366 0.0035
820 INCORRECT ROUTE OF DRUG ADMINISTRATION 125 0.0035
821 RASH MACULAR 122 0.0035
822 PANIC ATTACK 127 0.0035
823 FEELING ABNORMAL 833 0.0035
824 TREATMENT FAILURE 288 0.0035
825 JOINT SWELLING 418 0.0035
826 SKIN HAEMORRHAGE 51 0.0034
827 IMMUNODEFICIENCY 51 0.0034
828 PRURITUS 1308 0.0034
829 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 79 0.0034
830 DRUG INEFFECTIVE 4451 0.0034
831 MUSCULOSKELETAL DISORDER 64 0.0034
832 THIRST 60 0.0034
833 RASH ERYTHEMATOUS 160 0.0033
834 AGEUSIA 83 0.0033
835 ABDOMINAL DISCOMFORT 557 0.0033
836 MEMORY IMPAIRMENT 456 0.0033
837 LIVER DISORDER 147 0.0033
838 GASTROINTESTINAL HAEMORRHAGE 276 0.0033
839 BONE MARROW FAILURE 67 0.0033
840 NERVOUSNESS 172 0.0033
841 GAMMA-GLUTAMYLTRANSFERASE INCREASED 72 0.0032
842 DEVICE ISSUE 290 0.0032
843 CEREBRAL INFARCTION 79 0.0032
844 MULTIPLE FRACTURES 53 0.0032
845 DEVICE USE ERROR 112 0.0032
846 RASH PAPULAR 72 0.0032
847 ACUTE MYELOID LEUKAEMIA 50 0.0032
848 ABDOMINAL PAIN UPPER 658 0.0032
849 HAEMATEMESIS 81 0.0032
850 HEPATIC FAILURE 96 0.0032
851 MOVEMENT DISORDER 102 0.0032
852 FOETAL EXPOSURE DURING PREGNANCY 257 0.0032
853 UPPER GASTROINTESTINAL HAEMORRHAGE 53 0.0031
854 TRANSAMINASES INCREASED 70 0.0031
855 EPILEPSY 96 0.0031
856 NEUTROPENIA 427 0.0031
857 VISUAL IMPAIRMENT 386 0.0031
858 CEREBRAL HAEMORRHAGE 110 0.0031
859 FLATULENCE 173 0.0030
860 PLASMA CELL MYELOMA 119 0.0030
861 MELAENA 67 0.0030
862 HOT FLUSH 228 0.0030
863 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 51 0.0030
864 SYSTEMIC LUPUS ERYTHEMATOSUS 106 0.0030
865 LEUKOPENIA 149 0.0030
866 AGRANULOCYTOSIS 55 0.0030
867 CEREBROVASCULAR ACCIDENT 501 0.0030
868 BLOOD CREATINE PHOSPHOKINASE INCREASED 85 0.0029
869 HYPOACUSIS 127 0.0029
870 GLOSSODYNIA 66 0.0029
871 PROTEINURIA 56 0.0029
872 DYSGEUSIA 216 0.0029
873 RHABDOMYOLYSIS 121 0.0029
874 PRESCRIBED OVERDOSE 56 0.0029
875 NEOPLASM PROGRESSION 100 0.0029
876 PRODUCT PHYSICAL ISSUE 58 0.0029
877 OCULAR HYPERAEMIA 136 0.0029
878 CRYING 104 0.0029
879 ECZEMA 149 0.0028
880 MALIGNANT NEOPLASM PROGRESSION 291 0.0028
881 INTERNATIONAL NORMALISED RATIO INCREASED 81 0.0028
882 THERAPEUTIC RESPONSE UNEXPECTED 126 0.0028
883 HYPOGLYCAEMIA 136 0.0028
884 THERAPY INTERRUPTED 200 0.0028
885 DISEASE PROGRESSION 331 0.0028
886 THERAPEUTIC RESPONSE DECREASED 169 0.0028
887 MIDDLE INSOMNIA 52 0.0028
888 LABORATORY TEST ABNORMAL 82 0.0028
889 RHEUMATOID ARTHRITIS 314 0.0028
890 THERAPEUTIC PRODUCT EFFECT DECREASED 122 0.0027
891 ADVERSE DRUG REACTION 244 0.0027
892 SUICIDAL IDEATION 248 0.0027
893 EMOTIONAL DISORDER 83 0.0027
894 ABDOMINAL PAIN LOWER 68 0.0027
895 FEELING JITTERY 51 0.0027
896 TYPE 2 DIABETES MELLITUS 90 0.0027
897 BLOOD GLUCOSE DECREASED 128 0.0027
898 INJECTION SITE SWELLING 204 0.0027
899 EYE SWELLING 99 0.0027
900 DEMENTIA 74 0.0026
901 PSYCHOTIC DISORDER 78 0.0026
902 FAECES DISCOLOURED 57 0.0026
903 DEPRESSED MOOD 138 0.0026
904 ALOPECIA 511 0.0026
905 SKIN EXFOLIATION 218 0.0026
906 WITHDRAWAL SYNDROME 108 0.0026
907 HOSPITALISATION 395 0.0026
908 KNEE ARTHROPLASTY 54 0.0026
909 INTENTIONAL OVERDOSE 164 0.0026
910 LIVER INJURY 62 0.0025
911 HAEMATOCHEZIA 138 0.0025
912 CARDIOVASCULAR DISORDER 63 0.0025
913 RASH GENERALISED 64 0.0025
914 APPLICATION SITE PRURITUS 56 0.0025
915 TREATMENT NONCOMPLIANCE 135 0.0025
916 DRUG ADMINISTRATION ERROR 75 0.0024
917 EYE IRRITATION 140 0.0024
918 LACTIC ACIDOSIS 78 0.0024
919 INJECTION SITE MASS 89 0.0024
920 EXPIRED PRODUCT ADMINISTERED 80 0.0024
921 PANCREATITIS 127 0.0024
922 PSORIATIC ARTHROPATHY 97 0.0024
923 GASTRIC DISORDER 82 0.0024
924 THERAPEUTIC RESPONSE SHORTENED 79 0.0024
925 INJECTION SITE PAIN 730 0.0024
926 HEPATIC ENZYME INCREASED 162 0.0024
927 IRRITABILITY 142 0.0024
928 SKIN IRRITATION 107 0.0023
929 INJECTION SITE ERYTHEMA 287 0.0023
930 NEOPLASM MALIGNANT 154 0.0023
931 CONTRAINDICATED PRODUCT ADMINISTERED 69 0.0023
932 DEVICE MALFUNCTION 160 0.0023
933 INTERSTITIAL LUNG DISEASE 109 0.0022
934 WRONG TECHNIQUE IN DRUG USAGE PROCESS 81 0.0022
935 DEATH 1920 0.0022
936 FEMUR FRACTURE 69 0.0022
937 PRODUCT PRESCRIBING ERROR 53 0.0022
938 NO ADVERSE EVENT 401 0.0022
939 NIGHTMARE 76 0.0022
940 INJECTION SITE PRURITUS 146 0.0022
941 MOOD ALTERED 59 0.0022
942 ILL-DEFINED DISORDER 131 0.0022
943 FREQUENT BOWEL MOVEMENTS 58 0.0021
944 AGGRESSION 105 0.0021
945 DRUG EFFECT DECREASED 113 0.0021
946 EXTRAPYRAMIDAL DISORDER 52 0.0021
947 INJECTION SITE REACTION 141 0.0020
948 JAUNDICE 55 0.0020
949 INJECTION SITE BRUISING 160 0.0020
950 VAGINAL HAEMORRHAGE 87 0.0020
951 HEPATITIS 51 0.0020
952 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 58 0.0020
953 ABNORMAL BEHAVIOUR 78 0.0020
954 PAIN OF SKIN 53 0.0020
955 EYE PRURITUS 66 0.0020
956 MYOCARDIAL INFARCTION 342 0.0020
957 DRUG-INDUCED LIVER INJURY 61 0.0019
958 DRY SKIN 259 0.0019
959 ACCIDENTAL EXPOSURE TO PRODUCT 199 0.0019
960 MULTIPLE SCLEROSIS 92 0.0019
961 PRODUCT DOSE OMISSION 125 0.0019
962 LIVER FUNCTION TEST ABNORMAL 55 0.0019
963 INCORRECT DOSE ADMINISTERED 431 0.0019
964 DEVICE DIFFICULT TO USE 124 0.0019
965 ADVERSE EVENT 172 0.0019
966 DRUG EFFECT INCOMPLETE 66 0.0018
967 BLOOD GLUCOSE INCREASED 342 0.0018
968 MYELOSUPPRESSION 65 0.0018
969 DEVICE BREAKAGE 73 0.0018
970 SUICIDE ATTEMPT 107 0.0018
971 COMPLETED SUICIDE 146 0.0018
972 DRUG EXPOSURE DURING PREGNANCY 59 0.0017
973 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 350 0.0017
974 EXTRA DOSE ADMINISTERED 62 0.0015
975 PRODUCT SUBSTITUTION ISSUE 85 0.0015
976 LUNG NEOPLASM MALIGNANT 59 0.0014
977 INJECTION SITE HAEMORRHAGE 114 0.0014
978 THERAPY CESSATION 73 0.0014
979 DISEASE RECURRENCE 67 0.0014
980 MULTIPLE SCLEROSIS RELAPSE 95 0.0014
981 DRUG WITHDRAWAL SYNDROME 118 0.0013
982 COLITIS ULCERATIVE 60 0.0013
983 PSORIASIS 174 0.0013
984 DRUG DEPENDENCE 198 0.0012
985 DERMATITIS ATOPIC 64 0.0012
986 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 55 0.0012
987 SKIN BURNING SENSATION 84 0.0012
988 ACNE 86 0.0011
989 BREAST CANCER 101 0.0011
990 DRUG DOSE OMISSION 168 0.0010
991 UNDERDOSE 70 0.0010
992 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 57 0.0008
993 PRODUCT STORAGE ERROR 69 0.0008